MINNEAPOLIS, Oct. 23, 2018 /PRNewswire/ -- DaVita
Clinical Research (DCR), a subsidiary of DaVita Inc., (NYSE: DVA),
will present 19 research abstracts from company representatives and
collaborators at the American Society of Nephrology (ASN) annual
Kidney Week in San Diego from
Oct. 23-Oct. 28, 2018.
More than 13,000 kidney care professionals from around the world
convene at ASN Kidney Week to discuss new developments in the field
of nephrology.
"We look forward to ASN every year because it brings together
the best minds in nephrology and generates meaningful conversation
in the kidney care community," said Steven
Brunelli, MD, MSCE, vice president and medical director of
health economics and outcomes research for DaVita Clinical
Research. "We're eager to share our research and learn from others
so we can all continue to improve patient care."
Researchers will present results from several retrospective
studies and share data from innovative clinical improvement
programs.
This year's poster and presentation titles include:
DaVita Clinical Research
- Correspondence Between Causes of Recurrent Hospitalizations
Among Hemodialysis Patients
- Early Readmissions Are More Common After Long Hospitalizations
Among Hemodialysis Patients
DaVita Institute for Patient Safety, Inc. and DaVita Clinical Research
- Impact of Rescheduling a Missed Hemodialysis Treatment on
Clinical Outcomes
- Identification of Factors that Are Associated with Risk of
Modality Failure Among Patients Treated with Peritoneal
Dialysis
- Safety and Efficacy of Heparin During Dialysis in the Context
of Systemic Anticoagulant and Antiplatelet Medications
- Midodrine in the Context of Intradialytic Hypotension:
Association with Outcomes
- Effects of Oral Nutritional Supplements on Clinical Outcomes
and Nutritional Markers in Hemodialysis Patients Qualifying with
Serum Albumin 3.6 or 3.7 g/dL
DaVita Kidney Care
- A Peritonitis Surveillance System Developed by a Large Dialysis
Organization to Improve the Accuracy and Consistency of Peritonitis
Rate Reporting in the United
States
- Analysis of After-Hours Oral Antibiotic Protocol for the
Treatment of Suspected Peritonitis in Peritoneal Dialysis
Patients
DaVita International
- Patient Satisfaction Score in Relation to Hemodialysis
Guidelines and Practices: A European Multi-Center Analysis
- Effect of Hemofiltration on Anemia, Adequacy, and Bone Mineral
Disease in Hemodialysis Patients
- Impact of PEAK Methodology on Interdialytic Weight Gain: A
Multi-Center Experience
- Decreasing the Incidence of Catheter-Related Blood Stream
Infections in Hemodialysis Patients: A Quality Improvement
Program
- Are Cytokines and Body Composition Surrogate Markers for
Outcomes in Hemodialysis Patients?
- A European Hemodialysis Multi-Center Implementation of a
Standardized Diabetic Foot Examination Protocol
- Etelcalcetide in the Treatment of Secondary Hyperparathyroidism
in Patients Uncontrolled with Cinacalcet: Results from a
Prospective Study
- Daily Versus Post-Dialysis Administration of Calcimimetics for
the Treatment of Secondary Hyperparathyroidism in Hemodialysis
Patients: An Interventional, Multi-Center Study
- Low BMI Is Associated with Higher
Risk of Frequent Intradialytic Hypertension
- Impact of Patient Awareness and Age on Serum Albumin in Chronic
Hemodialysis Patients
Kidney Week attendees can visit booth 1929 to hear presentations
from DCR and DaVita Kidney Care clinical leaders or speak
to company representatives about partnering with DaVita.
To learn more about DCR, visit
www.DaVitaClinicalResearch.com.
About DaVita Clinical Research
DaVita Clinical
Research (DCR), a wholly owned subsidiary of DaVita Inc., is the
research arm of DaVita. DCR innovates through retrospective
research aimed at improving clinical outcomes. DCR assists
pharmaceutical and medical device companies in the design,
recruitment and completion of clinical trials using its renal
research site network. To learn more about DCR, visit
DaVitaClinicalResearch.com.
About DaVita Inc.
DaVita Inc., a Fortune 500®
company, is the parent company of DaVita Kidney Care and
DaVita Medical Group. DaVita Kidney Care is a leading
provider of kidney care in the United States, delivering dialysis services to
patients with chronic kidney failure and end stage renal disease.
As of June 30, 2018, DaVita Kidney Care operated or
provided administrative services at 2,580 outpatient dialysis
centers located in the United States serving
approximately 201,000 patients. The company also operated 253
outpatient dialysis centers located in 10 countries
outside the United States.
DaVita Medical Group manages and operates medical groups and
affiliated physician networks
in California, Colorado, Florida, Nevada, New
Mexico and Washington in its pursuit to deliver
excellent-quality health care in a dignified and compassionate
manner. DaVita Medical Group's teammates, employed clinicians and
affiliated clinicians provided care for approximately 1.7 million
patients. For more information, please
visit DaVita.com/About.
Contact Information
Media:
Ashley Henson
(303) 876-6626
Ashley.Henson@davita.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/american-society-of-nephrology-annual-kidney-week-features-findings-from-davita-clinical-research-300735772.html
SOURCE DaVita Clinical Research